The Investor Notebook

7 Nov 2024

PM Discussion (Emerging Companies Fund) – October 2024

Related articles

New blood

General stock market health, here and abroad, and improving investor confidence will prove to be the transmission mechanism for healthy IPO outcomes in 2025.
2 Jan 2025

Read more

The Encyclical June Quarter 2024

The Encyclical June Quarter 2024
23 Oct 2024

Read more

2025 Earnings outlook

Encouraging to read of the growing confidence around the 2025 earnings outlook for the S&P500. Goldman Sachs believe 2025 eps growth will be ~11%, following on from ~8% in 2024.
13 Dec 2024

Read more

Invest Now

About us

Funds

Investor Portals

The Investor Notebook

Contact